Drug Profile
Hepatitis B vaccine recombinant - Genentech
Alternative Names: Gamma-HBLatest Information Update: 01 Oct 2007
Price :
$50
*
At a glance
- Originator Genentech
- Developer Daiichi Sankyo Company; Genentech; Mitsubishi Chemical; Mitsubishi Tanabe Pharma Corporation
- Class DNA vaccines; Hepatitis B vaccines; Synthetic vaccines
- Mechanism of Action Immunostimulants
-
Orphan Drug Status
Orphan designation is assigned by a regulatory body to encourage companies to develop drugs for rare diseases.
Highest Development Phases
- Marketed Hepatitis B
Most Recent Events
- 01 Oct 2007 Mitsubishi Pharma Corporation has merged with Tanabe Seiyaku to form Mitsubishi Tanabe Pharma Corporation
- 03 Apr 2006 Daiichi Pharmaceutical has merged with Sankyo to form Daiichi Sankyo Inc
- 16 Nov 1999 Tokyo Tanabe has been acquired by Mitsubishi Chemical